Cohen Neil Harrisinsider trades
In SEC Form 4 filings, Cohen Neil Harris is listed as Director of Chemomab Therapeutics Ltd. (CMMB). In the last 90 days, Cohen Neil Harris sold $6.5K of Chemomab Therapeutics Ltd. (CMMB) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CMMBChemomab Therapeutics Ltd. | Director | 9 | Sep 1 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CMMBChemomab Therapeutics Ltd. | Aug 28 | Sep 1 | S | 1,000 | $2.80 | Sale −$2,800 | 33,000 | No | Form 4 |
| CMMBChemomab Therapeutics Ltd. | Aug 27 | Sep 1 | S | 1,304 | $2.85 | Sale −$3,716 | 34,000 | No | Form 4 |
| CMMBChemomab Therapeutics Ltd. | Mar 16 | Sep 1 | A · derivative | 5,172 | $2.14 | $11,068 | 18,075 | No | Form 4 |
| CMMBChemomab Therapeutics Ltd. | Mar 16, 2025 | Sep 1 | A · derivative | 3,821 | $6.16 | $23,537 | 12,903 | No | Form 4 |
| CMMBChemomab Therapeutics Ltd. | Mar 18, 2024 | Sep 1 | A · derivative | 2,520 | $2.96 | $7,459 | 9,082 | No | Form 4 |
| CMMBChemomab Therapeutics Ltd. | Mar 21, 2023 | Sep 1 | A · derivative | 1,714 | $6.48 | $11,107 | 6,562 | No | Form 4 |
| CMMBChemomab Therapeutics Ltd. | Mar 7, 2022 | Sep 1 | A · derivative | 1,705 | $14.12 | $24,075 | 4,848 | No | Form 4 |
| CMMBChemomab Therapeutics Ltd. | Apr 19, 2021 | Sep 1 | A · derivative | 2,971 | $109.04 | $323,958 | 3,143 | No | Form 4 |
| CMMBChemomab Therapeutics Ltd. | Jul 16, 2020 | Sep 1 | A · derivative | 172 | $52.80 | $9,082 | 172 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.